Hespecta Vaccination in HPV+ Tumors or Malignant Lesions

NCT02821494 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Tumors or Premalignant Lesions

Interventions

BIOLOGICAL: Hespecta

Sponsor

Leiden University

Collaborators

[object Object]
[object Object]
[object Object]